Feige’s Venom Hope Masks Sony’s Deeper Marvel Lock-In

Kevin Feige and Amy Pascal say they always have hope for a Spider-Man and Venom crossover. The line lands on the eve of Spider-Man: Brand New Day, Tom Holland’s fourth solo outing, and it is the same polite non-answer fans have heard for years.

What sits behind the hope is clearer. Sony’s attempt at a standalone Spider-adjacent universe collapsed. The Marvel partnership that produces the Holland films is now the only reliable engine left, and the producers are already sketching the next two to five pictures plus a live-action Miles Morales once the animated Spider-Verse trilogy ends.

The Podcast Exchange That Gave Fans Nothing New

Josh Horowitz asked the producers of Brand New Day on the Happy Sad Confused podcast how close they had come to putting Tom Hardy’s Eddie Brock opposite Holland’s Peter Parker. The absence of any shared scene after three Venom movies and multiple Spidey films has become a running fan grievance.

It would be great, let’s put it that way.

Pascal offered that first. When Horowitz pressed on whether hope remained, Feige answered, “Always have hope.” Pascal added, “I have hope. We have hope.”

The exchange is not a denial. It is also not a schedule, a script commitment, or confirmation that Hardy’s version is still the plan. Online reaction treated the phrase as polished stalling after three Venom films that never delivered the promised meeting. An animated Venom feature from Final Destination: Bloodlines directors Zach Lipovsky and Adam B. Stein remains in development at Sony Pictures Animation, with Pascal and Hardy linked in some capacity, but that project sits outside the live-action MCU track.

Sony’s Solo Universe Left Only One Working Path

The context for the hope talk is the wreckage of Sony’s wider ambitions. Morbius, Madame Web and Kraven the Hunter all failed to connect with audiences. Those flops effectively ended the idea of a self-contained Sony Spider-verse of street-level villains and anti-heroes running parallel to Marvel Studios.

• Morbius opened to poor reviews and faded fast despite a mid-credits Venom tease.
• Madame Web struggled to find an audience and became a critical punchline.
• Kraven the Hunter continued the pattern of expensive underperformance.

The Holland Spider-Man films, by contrast, have been among Sony’s most profitable theatrical outings precisely because they sit inside the Marvel system. Feige and Pascal have now worked together on these movies for a decade since Homecoming. In a recent interview they described the relationship as almost unchanged and “astonishing” for two studios. That stability is the actual asset.

Brand New Day Resets Peter Parker Alone

Brand New Day, directed by Destin Daniel Cretton, picks up four years after No Way Home. Peter Parker lives with the fallout of the spell that erased him from the memories of everyone he loves. He is a full-time street-level Spider-Man in a New York that no longer knows his name. The official Brand New Day synopsis and July 31 date frame a surprising physical evolution that threatens his existence while he fights an invisible threat.

Feige and Pascal have said they stood up and cheered after the director’s cut. The film brings in Jon Bernthal’s Punisher and Mark Ruffalo’s Hulk because both characters share isolation and a complicated relationship to doing the right thing. Sadie Sink plays a new character whose identity has been tightly held. Classic comic and PlayStation visual language shape the swinging sequences. Cretton has spoken of a giant multi-villain fight that was cut, with the possibility it returns in a later film.

None of the marketing or producer comments point to symbiotes or Venom in this chapter. Rumors that Brand New Day would feature them proved inaccurate. The movie is built as the start of a more personal, comic-friendly stretch rather than a multiversal guest-star party.

Rothman Frames It as Ongoing Business, Not Crossover Theater

At the Los Angeles premiere, Sony Pictures chairman Tom Rothman was asked about more collaborations with Marvel and Disney. He pushed back on the “crossover” framing itself.

“I don’t really think of this as a crossover per se. The Spider-Man movies have always been Spider-Man-led. Yes, there is a wonderfully mutually beneficial relationship between Sony Pictures and Marvel and Disney, and it has worked out great, so I would hope so.”

That language matches the producers. The films stay Spider-Man-led. Marvel creative involvement and the shared universe benefits remain the commercial engine. After the spinoff losses, Sony has little incentive to look the gift horse in the mouth again. The same logic underpins talk of possible future live-action Miles Morales or Black Cat projects as collaborations rather than independent Sony ventures.

The Real Map Runs Past Venom to Miles and Multiple Sequels

While the Venom hope generates headlines, Feige has been more specific about the longer slate. Speaking to China’s Watching Hollywood, he confirmed plans for live-action Miles Morales once Sony’s animated Spider-Verse series concludes with Beyond the Spider-Verse on June 18, 2027.

“We definitely have plans [for a live-action Miles], and I think a live-action Spider-Man movie has this destiny: to add Miles sometime after the Spider-Verse series ends.” He added that he and Pascal “have had in-depth discussions about what the next two, three, four, and five Spider-Man movies might be about.” That matches Feige’s plans for live-action Miles after Spider-Verse reported earlier this month.

Pascal has previously said a live-action Miles project is happening. The animated side continues too; Sony has already confirmed further Spider-Verse expansions including Sony animated Spider-Gwen and Spider-Punk plans. Holland himself has spoken of wanting to produce future franchise entries and has floated Owen Cooper as a possible later Peter Parker, but the immediate plan keeps him in the suit.

Holland’s schedule has already forced one major accommodation. He delayed Brand New Day production to shoot Tom Holland’s parallel Odyssey role for Christopher Nolan. The franchise is flexible enough to absorb that kind of star demand because the financial upside remains enormous.

Opening Numbers Will Decide How Fast the Slate Moves

Brand New Day arrives with tracking that would rank among the largest openings in history. Domestic estimates have climbed into the $260 million to $300 million range, with some models higher. International projections sit in the $275 million to $300 million zone or above. Global opening talk has ranged from the mid-$400 millions upward. A finish near or above No Way Home’s territory would immediately green-light the multi-film discussions already under way.

Those figures matter more than any single crossover tease. Strong performance turns the “next two, three, four, and five” conversations into dated productions. Weakness would not kill the partnership, but it would slow the cadence. Either way, the Venom question remains optional seasoning rather than the main course.

Comics Already Deliver What the Films Keep Teasing

While live-action waits, the page has moved on. Marvel’s current Amazing Spider-Man / Venom: Death Spiral event puts the characters together with Carnage in a major storyline that includes major status-quo shifts. Readers who want the team-up can already buy the comics Spider-Man Venom Carnage team-up event. The films operate on a different clock set by rights, actor availability, and the need to protect the Holland series’ brand.

Hardy and Holland once played father and son in the 2013 film Locke. That coincidence has fueled fan casting for years. Whether any future film uses Hardy, recasts Eddie Brock, or skips the character entirely is still open. Feige’s “always have hope” keeps every option alive at zero cost.

Brand New Day opens July 31. The producers have given fans the line they wanted to hear. The contracts, the slate documents, and the box-office models are already pointed at a longer, more integrated Spider-Man future that does not depend on one symbiote meeting.